Αποτελέσματα Αναζήτησης
7 Μαρ 2024 · This hormone plays a key role in female sexual function, even though testosterone level is much lower in women than in men. In the United States, testosterone isn't approved by the FDA to treat sexual conditions in women. Still, sometimes it's prescribed to help lift a lagging libido.
19 Αυγ 2015 · The U.S. Food and Drug Administration has approved Addyi (flibanserin) – making it the first and only drug designed to help increase women's sexual desire.
22 Δεκ 2023 · The FDA has approved a daily pill called flibanserin (Addyi) to treat low sexual desire in women before menopause. This medicine started as a treatment for depression. Addyi may boost sex drive in women with low sexual desire.
26 Ιαν 2024 · The Food and Drug Administration (FDA) have approved two drugs — flibanserin (Addyi) and bremelanotide (Vyleesi) — to address low desire or arousal in females. However, both are approved for use...
12 Φεβ 2021 · Addyi (flibanserin), a drug dubbed the ‘female Viagra’, has been approved for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women by the US Food and Drug Administration (FDA).
21 Ιουν 2019 · The FDA approved Vyleesi (bremelanotide), a new medication for pre-menopausal women with female hypoactive sexual desire disorder, or HSDD.
29 Οκτ 2021 · Women whose sex drive needs a boost now have a pill they can take. The first prescription drug to treat low sex drive in women gained FDA (U.S. Food and Drug Administration) approval in August 2015. The drug is flibanserin (Addyi) and it’s a breakthrough for women’s sexual health.
